San Francisco updates monkeypox vaccination strategy amidst rising cases and community concerns
July 19, 2022 | San Francisco City, San Francisco County, California
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
The San Francisco Health Commission convened on July 4, 2025, to address pressing public health issues, including updates on the monkeypox outbreak and discussions surrounding potential mask mandates in response to rising COVID-19 cases.
The meeting began with a brief acknowledgment of the ongoing challenges posed by infectious diseases, particularly in light of the recent monkeypox outbreak. Dr. Phillips provided a detailed update, noting that there have been 14,000 monkeypox cases reported worldwide, with over 1,800 in the United States and 141 in San Francisco alone. The demographic breakdown revealed that the majority of cases are among individuals aged 25 to 54, with a significant proportion identifying as white and male.
Dr. Phillips emphasized the critical role of vaccination in controlling the outbreak, highlighting the limited supply of the JYNNEOS vaccine. San Francisco has requested 35,000 doses but has only received approximately 7,000 to date. The city is prioritizing vaccination for high-risk groups, including gay and bisexual men, and plans to expand eligibility to include sex workers.
The discussion then shifted to public health strategies, including testing and treatment options for monkeypox. Dr. Phillips noted improvements in local testing capabilities, which have increased significantly since the initial outbreak. However, access to antiviral treatments remains limited, necessitating ongoing efforts to streamline distribution and administration.
As the meeting progressed, public comments reflected growing concerns about the lack of a mask mandate in light of rising COVID-19 cases. Several callers urged the Health Commission to reinstate indoor mask requirements, citing high community transmission rates and the need to protect vulnerable populations. They expressed frustration over perceived inaction and called for stronger public health measures to ensure safety in public spaces, particularly on public transit.
The Health Commission acknowledged these concerns and reiterated its commitment to addressing public health challenges through equitable access to vaccines and effective communication strategies. The meeting concluded with a commitment to continue monitoring the situation and to engage with community partners to enhance public health responses.
Overall, the meeting underscored the ongoing challenges faced by San Francisco in managing infectious diseases and the importance of community engagement in shaping public health policy. The Health Commission is expected to consider the feedback received during public comments as it navigates the complexities of the current health landscape.
The meeting began with a brief acknowledgment of the ongoing challenges posed by infectious diseases, particularly in light of the recent monkeypox outbreak. Dr. Phillips provided a detailed update, noting that there have been 14,000 monkeypox cases reported worldwide, with over 1,800 in the United States and 141 in San Francisco alone. The demographic breakdown revealed that the majority of cases are among individuals aged 25 to 54, with a significant proportion identifying as white and male.
Dr. Phillips emphasized the critical role of vaccination in controlling the outbreak, highlighting the limited supply of the JYNNEOS vaccine. San Francisco has requested 35,000 doses but has only received approximately 7,000 to date. The city is prioritizing vaccination for high-risk groups, including gay and bisexual men, and plans to expand eligibility to include sex workers.
The discussion then shifted to public health strategies, including testing and treatment options for monkeypox. Dr. Phillips noted improvements in local testing capabilities, which have increased significantly since the initial outbreak. However, access to antiviral treatments remains limited, necessitating ongoing efforts to streamline distribution and administration.
As the meeting progressed, public comments reflected growing concerns about the lack of a mask mandate in light of rising COVID-19 cases. Several callers urged the Health Commission to reinstate indoor mask requirements, citing high community transmission rates and the need to protect vulnerable populations. They expressed frustration over perceived inaction and called for stronger public health measures to ensure safety in public spaces, particularly on public transit.
The Health Commission acknowledged these concerns and reiterated its commitment to addressing public health challenges through equitable access to vaccines and effective communication strategies. The meeting concluded with a commitment to continue monitoring the situation and to engage with community partners to enhance public health responses.
Overall, the meeting underscored the ongoing challenges faced by San Francisco in managing infectious diseases and the importance of community engagement in shaping public health policy. The Health Commission is expected to consider the feedback received during public comments as it navigates the complexities of the current health landscape.
View the Full Meeting & All Its Details
This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.
✓
Watch full, unedited meeting videos
✓
Search every word spoken in unlimited transcripts
✓
AI summaries & real-time alerts (all government levels)
✓
Permanent access to expanding government content
30-day money-back guarantee
